Nabriva Therapeutics plans to raise $25.4M through stock sale
March 02, 2021 at 10:41 AM EST
The company specializes in developing antibiotics to treat serious infections.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|